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scores range from 0.20 to 1.28. Third, we assessed the
sensitivity of the LOD scores to the disease model when
the parameters are adjusted to make the predicted
prevalence consistent with the observed prevalence.
Model F ( ), which differs from model Eqp 0.026
( ) only in the value of disease-allele frequencyqp 0.001
q, has slightly lower LOD scores at small values of v
than model E. Model G, which differs from model E
only in the phenocopy rate (model G ), alsof p 0.050
has smaller LOD scores at small values of v than model
E. Thus, increasing the disease-allele frequency or the
phenocopy rate to bring the population prevalence K up
to ∼5% lowered the LOD score slightly.
Chen et al. (2004) claim to have identified a “signif-
icant” RLS susceptibility locus on chromosome 9p24-
22. Their results might not actually be significant, as a
result of the many methodological errors we have de-
scribed above. The use of equal marker-allele frequen-
cies, overinterpretation of the significance of the NPL
scores, and “validation” analysis in only 2 of the 15
families are some of the potential problems that lead us
to believe that there is no convincing evidence for an
RLS locus on chromosome 9p. Chen et al. (2004) should
model linkage heterogeneity and should use the proper
marker-allele frequencies, penetrances, and disease-allele
frequency when they reanalyze their data.
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Reply to Ray and Weeks: Linkage for Restless Legs
Syndrome on Chromosome 9p Is Significant
To the Editor:
Ray and Weeks (2005 [in this issue]) discussed some
concerns about the statistical methodology of our ge-
nomewide linkage-scan study that identified a novel sus-
ceptibility locus for restless legs syndrome (RLS) on
chromosome 9p24-22 (Chen et al. 2004). Before we
systematically address their concerns, it is important
to note that the 9p24-22 RLS locus has been replicated
in a large family from Germany, with a significant LOD
score found by an independent research group (J. Win-
kelmann, personal communication). This independent
replication in a different study population has strongly
validated our initial linkage finding.
The Genetic Component of RLS: We are aware of the
issue of a bias in estimation of familial correlations and
heritability in a population enrolled for genetic stud-
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Table 1
Revised Pairwise LOD Scores between RLS and Chromosome
9p24-22 Markers Obtained by Model-Based Linkage Analysis
in Two Extended Kindreds with RLS
MARKER AND
KINDRED
LOD SCORE AT v p
.00 .05 .10 .20 .30 .40
D9S1779:
40004 .00 .00 .00 .00 .00 .00
40015 1.32 .11 .24 .20 .05 .03
Total 1.32 .11 .24 .20 .05 .03
D9S1871:
40004 .30 .28 .25 .20 .14 .08
40015 1.90 1.75 1.59 1.25 .88 .47
Total 2.20 2.03 1.84 1.45 1.02 .55
D9S2169:
40004 .60 .56 .51 .40 .29 .16
40015 1.87 1.70 1.53 1.17 .78 .38
Total 2.47 2.26 2.04 1.57 1.07 .54
D9S286:
40004 1.49 1.36 1.22 .92 .58 .25
40015 2.04 1.86 1.68 1.31 .91 .48
Total 3.53 3.22 2.90 2.23 1.49 .73
D9S168:
40004 .00 .00 .00 .00 .00 .00
40015 1.87 1.70 1.53 1.16 .78 .37
Total 1.87 1.70 1.53 1.16 .78 .37
D9S268:
40004 .18 .10 .02 .11 .15 .10
40015 1.54 1.41 1.27 .99 .69 .35
Total 1.72 1.51 1.29 .88 .54 .25
D9S274:
40004 1.19 1.07 .93 .66 .38 .13
40015 1.91 1.75 1.59 1.25 .88 .48
Total 3.10 2.82 2.52 1.91 1.25 .61
D9S1839:
40004 .00 .00 .00 .00 .00 .00
40015 .80 .70 .60 .40 .21 .06
Total .80 .70 .60 .40 .21 .06
D9S162:
40004 1.41 .18 .02 .12 .07 .00
40015 2.04 1.88 1.70 1.31 .92 .47
Total .63 1.70 1.72 1.43 .99 .47
D9S1121:
40004 1.95 1.24 .80 .40 .23 .13
40015 .15 .13 .10 .06 .03 .01
Total 1.80 1.11 .70 .34 .20 .12
NOTE.—LOD scores were computed with the assumption of a
disease-gene frequency of 0.001, a penetrance rate of 95%, a phe-
nocopy rate of 0.001 (as used in the original analysis), and marker-
allele frequencies estimated by maximum likelihood. The combined
LOD score for D9S286 at is 3.49 when the disease-gene fre-vp 0
quency is increased to 0.003 and the phenocopy rate is increased to
0.005 and is 3.24 with a disease-gene frequency of 0.003, a phe-
nocopy rate of 0.05, and a penetrance rate of 0.95.
ies. Therefore, we clearly stated this in our article (e.g.,
in the “Results” section, we noted, “The derived her-
itability…was 0.60, which indicates that RLS is a highly
heritable trait in this ascertained cohort,” and, in the
“Discussion” section, we noted, “It is important to note
that familial correlations and heritability were estimated
for an ascertained cohort, and the results may not be
generalizable to the RLS population at large” [Chen et
al. 2004, pp. 881 and 882]). Since the sampling schemes
for the recruited RLS pedigrees are complicated and
cannot be described by a single form of ascertainment,
a formulated correction for ascertainment bias was
not undertaken because of the lack of an appropriate
method and software package. Nevertheless, our con-
clusion about the genetic nature of the disease was based
on the analysis of diverse types of relative pairs. A large
number of relative pairs of more remote types (i.e., sec-
ond-, third-, and fourth-degree relations) were used for
the inference, and these data might be less influenced by
the ascertainment. We agree that familial risk-ratio es-
timation by use of the ascertained cohort could be bi-
ased, and a high population prevalence of 12% was thus
used to obtain a conservative estimate. The determina-
tion of the genetic component of a complex human dis-
ease will perhaps continue to be a critical issue, since
human pedigrees are often ascertained from clinical set-
tings, and the sampling schemes may not be defined by
a single ascertainment form. Nevertheless, genetic anal-
ysis of the collected samples for evidence of genetic fac-
tors, as a requisite step toward identification of disease
genes, cannot be ignored. Without familial aggregation
in which genetic factors play an important role, the ex-
pense and effort involved in further gene mapping and
cloning would be wasted (Farrer and Cupples 1998).
Model-Free Linkage Analysis: Ray and Weeks (2005)
were concerned about our reporting of statistical sig-
nificance. However, their arguments, which are based on
the criteria of Lander and Kruglyak (1995) and rough
transformation between different statistics through
only the link of a P value (see table 1 in Ray and Weeks
2005), may not be the most appropriate. First, Lander
and Kruglyak’s criteria for genomewide significance
were based on a dense map and on complete information
extraction, which do not apply to our experiment, which
had a less dense marker map (10-cM density, on average)
and a fraction of missing genotypes. Using extensive sim-
ulations, Wiltshire et al. (2002) demonstrated that the
criteria proposed by Lander and Kruglyak (1995) were
too stringent for an initial 10-cM genome scan. Second,
direct translation of a P value for different statistics can
be criticized because of the high reliance of P values on
sample sizes (Witte et al. 1996), especially for a small-
to-medium sample size like that of our study. Third, a
nominal P value derived from the asymptotic distribu-
tion of a linkage statistic can be different from the es-
timate obtained from permutation. In other words, the
asymptotic distribution of a statistic can deviate sub-
stantially from the observed value, especially for small
sample sizes. Fourth, the nonparametric linkage (NPL)
statistic used in our genomewide scan is deemed to be
quite conservative, meaning that P values of .05 occur
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Figure 1 Multipoint LOD-score analysis for markers at the 9p24-22 RLS locus. Only one member of the twin pair was included in the
analysis. The parameters used for the analysis include a disease-gene frequency of 0.001, marker-allele frequencies estimated by maximum
likelihood, a penetrance rate of 0.95, and a phenocopy rate of 0.001.
less often than expected (Haines 1998). Thus, direct
exchange between LOD and NPL measures is highly
questionable. Since unified criteria for significant and
suggestive linkages based on NPL scores have not been
described in the literature, we defined NPL scores of
3.0 as significant evidence of linkage and scores of
2.0 as suggestive evidence of linkage on the basis of
the nominal empirical P values. Similar criteria have
been used by others (Kaminen et al. 2003; Laivuori et
al. 2003; Friedrichsen et al. 2004; Middleton et al.
2004). Most importantly, our claim of significant linkage
at the 9p RLS locus was based on multiple lines of ev-
idence from NPL analysis, Haseman-Elston sib-pair re-
gression (P value at the peak !105; authors’ unpub-
lished data), and model-based linkage analysis.
Model-Based Linkage Analysis: In our study (Chen et
al. 2004), we calculated the LOD scores using the pro-
gram Linkage Package 5.2 (MLINK) directly connected
to the pedigree program Cyrillic 2, which apparently
treated twins as full siblings. This treatment leads to the
upper-limit estimation of LOD scores. We have now re-
calculated the LOD scores by deleting the data from one
member of the twin pair in the analysis. The linkage
remains significant (table 1).
For model-based linkage analysis of one or a few ped-
igrees, the assumptions of the disease-gene frequency,
marker-allele frequencies, penetrance, and phenocopy
rates are largely based on educated guesses. These as-
sumptions may vary among different research groups,
since the genetic architecture of the disease is not clear
in most cases. A disease-gene frequency of 0.026, as
suggested by Ray and Weeks (2005), is too high, since
RLS is genetically highly heterogeneous; many genes
may be involved in development of RLS, and the fre-
quency of one specific gene—for example, the chro-
mosome 9p RLS gene—is expected to be much lower.
The assumption made by Ray and Weeks (2005) is not
realistic unless a single gene is the cause of the disorder
in all patients with RLS (5%–12% of the population).
To date, two other RLS loci have already been mapped
to chromosomes 12 and 14, and many families do not
link to the three known RLS loci (Desautels et al. 2001;
Bonati et al. 2003; Chen et al. 2004).
To investigate whether the 1/n method (i.e., the as-
sumption that there are equal allelic frequencies and that
n equals the total number of alleles observed in the fam-
ilies studied) could lead to false evidence of linkage for
these particular data, we calculated the LOD scores for
our genotyping data by using the allele frequencies that
were estimated with the maximum-likelihood meth-
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od. The linkage for the 9p RLS linkage remains sig-
nificant, with a combined two-point LOD score of 3.53
at D9S286 (table 1) and a multipoint LOD score of 3.56
(fig. 1). (Note that these LOD scores were obtained when
one member of the twin pair was removed from the
analysis, and the overall LOD scores slightly increased
when actual allele frequencies were used, as compared
with the use of 1/n allele frequencies: 3.53 vs. 3.52 for
D9S286 and 3.10 vs. 2.95 for D9S274.) These results
indicate that the LOD scores for the 9p RLS linkage do
not change much if the maximum-likelihood estimates
of the sample allele frequencies are used.
For model-based linkage analysis, genotyping is com-
monly performed for multiple mid- to large-size families,
but linkage at a specific locus may be identified and
reported in a subset of the families, since other families
may be associated with different disease genes. We agree
that model-based linkage analysis can also be performed
for our complete genotyping data with the assump-
tion of heterogeneity. To calculate heterogeneity LOD
(HLOD) scores, we used the GeneHunter-Plus program,
which maximizes the LOD scores over both recom-
bination fraction v and admixture parameter a. The
HLOD score at the 9p RLS locus, with the assumption
of autosomal dominant inheritance, reached 2.31. Sim-
ilar results were obtained with the program HOMOG
(HLOD p 2.46, with the assumption of autosomal
dominant inheritance). These results are consistent with
our original conclusion of the identification of an RLS
locus on chromosome 9p24-22.
In summary, we feel that our evidence of genetic link-
age for RLS on chromosome 9p is methodologically
sound, and our finding is buttressed by the independent
replication in a different population.
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